Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth (NASDAQ:IRWD)

This article was written by Follow Biologics is a full-time healthcare investor who developed a passion…

Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals

Newer and more expensive medications are more likely to be made in the United States or…

Centessa Pharmaceuticals: Smooth Move To New Programs, But Questions Remain (NASDAQ:CNTA)

This article was written by Follow Avisol Capital Partners is made up of a team of…